Cargando…
The Differential Metabolic Signature of Breast Cancer Cellular Response to Olaparib Treatment
SIMPLE SUMMARY: Breast cancer remains a leading cause of female cancer related mortality worldwide. Loss of genomic stability and dysregulation of cellular metabolism are well-recognized features of breast cancer, presenting an opportunity to study the drivers of breast cancer progression and resist...
Autores principales: | Berardi, Domenica, Hunter, Yasmin, van den Driest, Lisa, Farrell, Gillian, Rattray, Nicholas J. W., Rattray, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367310/ https://www.ncbi.nlm.nih.gov/pubmed/35954325 http://dx.doi.org/10.3390/cancers14153661 |
Ejemplares similares
-
Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets
por: Alnoumas, Layla, et al.
Publicado: (2022) -
An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
por: Kelly, Patricia E., et al.
Publicado: (2022) -
Elucidating the mechanisms of TDP-43 aggregation in a cellular model of motor neuron disease
por: Hicks, David, et al.
Publicado: (2015) -
A Bayesian model selection approach for identifying differentially expressed transcripts from RNA sequencing data
por: Papastamoulis, Panagiotis, et al.
Publicado: (2017) -
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
por: Batalini, Felipe, et al.
Publicado: (2022)